TNA
DGX icon

True North Advisors’s Quest Diagnostics DGX Stock Holding History

True North Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$402K Buy
1,897
+367
+24% +$72K 0.04% 202
2026
Q1 		$300K Sell
1,530
-38
-2% -$7.38K 0.03% 206
2025
Q4 		$272K Buy
1,568
+14
+0.9% +$2.55K 0.04% 220
2025
Q3 		$296K Buy
1,554
+61
+4% +$10.8K 0.05% 172
2025
Q2 		$268K Buy
1,493
+5
+0.3% +$868 0.05% 195
2025
Q1 		$252K Hold
1,488
– – 0.04% 217
2024
Q4 		$224K Buy
+1,488
New +$231K 0.05% 175

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

True North Advisors's DGX Position: Q2 2026 in Review

True North Advisors increased its Quest Diagnostics (DGX) stake by 24% in Q2 2026, buying an estimated $72K and bringing the position to 1,897 shares worth $402K. The position accounts for 0.04% of the portfolio, ranked #202.

True North Advisors first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • True North Advisors held 1,897 shares of Quest Diagnostics worth $402K as of Q2 2026.
  • True North Advisors bought 367 Quest Diagnostics shares in Q2 2026, an estimated $72K.
  • Quest Diagnostics made up 0.04% of True North Advisors's portfolio in Q2 2026, its #202 holding.
  • True North Advisors first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on True North Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.